Structure

Physi-Chem Properties

Molecular Weight:  216.15
Volume:  243.208
LogP:  3.863
LogD:  3.673
LogS:  -4.516
# Rotatable Bonds:  1
TPSA:  20.23
# H-Bond Aceptor:  1
# H-Bond Donor:  1
# Rings:  3
# Heavy Atoms:  1

MedChem Properties

QED Drug-Likeness Score:  0.757
Synthetic Accessibility Score:  3.611
Fsp3:  0.6
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.684
MDCK Permeability:  2.2546237232745625e-05
Pgp-inhibitor:  0.012
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.003
20% Bioavailability (F20%):  0.892
30% Bioavailability (F30%):  0.809

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.234
Plasma Protein Binding (PPB):  96.78898620605469%
Volume Distribution (VD):  2.56
Pgp-substrate:  5.137005805969238%

ADMET: Metabolism

CYP1A2-inhibitor:  0.828
CYP1A2-substrate:  0.913
CYP2C19-inhibitor:  0.775
CYP2C19-substrate:  0.91
CYP2C9-inhibitor:  0.451
CYP2C9-substrate:  0.806
CYP2D6-inhibitor:  0.621
CYP2D6-substrate:  0.888
CYP3A4-inhibitor:  0.796
CYP3A4-substrate:  0.565

ADMET: Excretion

Clearance (CL):  9.456
Half-life (T1/2):  0.281

ADMET: Toxicity

hERG Blockers:  0.059
Human Hepatotoxicity (H-HT):  0.061
Drug-inuced Liver Injury (DILI):  0.041
AMES Toxicity:  0.058
Rat Oral Acute Toxicity:  0.086
Maximum Recommended Daily Dose:  0.717
Skin Sensitization:  0.934
Carcinogencity:  0.206
Eye Corrosion:  0.916
Eye Irritation:  0.985
Respiratory Toxicity:  0.937

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC64586

Natural Product ID:  NPC64586
Common Name*:   Cyclolauren-2-Ol
IUPAC Name:   5-[(1S,2R,5R)-1,2-dimethyl-2-bicyclo[3.1.0]hexanyl]-2-methylphenol
Synonyms:   Cyclolauren-2-ol
Standard InCHIKey:  CVIXDDABZMVCMV-SNPRPXQTSA-N
Standard InCHI:  InChI=1S/C15H20O/c1-10-4-5-11(8-13(10)16)14(2)7-6-12-9-15(12,14)3/h4-5,8,12,16H,6-7,9H2,1-3H3/t12-,14+,15+/m1/s1
SMILES:  Cc1ccc(cc1O)[C@]1(C)CC[C@@H]2C[C@]12C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL512942
PubChem CID:   11390308
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001550] Sesquiterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO6250 Laurencia tristicha Species Rhodomelaceae Eukaryota n.a. n.a. n.a. PMID[15974618]
NPO6250 Laurencia tristicha Species Rhodomelaceae Eukaryota n.a. n.a. n.a. PMID[27536968]
NPO6250 Laurencia tristicha Species Rhodomelaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT81 Cell Line A549 Homo sapiens IC50 > 10.0 ug.mL-1 PMID[464335]
NPT547 Cell Line BGC-823 Homo sapiens IC50 > 10.0 ug.mL-1 PMID[464335]
NPT181 Cell Line Bel-7402 Homo sapiens IC50 > 10.0 ug.mL-1 PMID[464335]
NPT180 Cell Line HCT-8 Homo sapiens IC50 > 10.0 ug.mL-1 PMID[464335]
NPT165 Cell Line HeLa Homo sapiens IC50 > 10.0 ug.mL-1 PMID[464335]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC64586 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9223 High Similarity NPC310456
0.92 High Similarity NPC299762
0.92 High Similarity NPC33675
0.91 High Similarity NPC6597
0.91 High Similarity NPC79241
0.9048 High Similarity NPC306295
0.902 High Similarity NPC252105
0.9 High Similarity NPC312132
0.9 High Similarity NPC259512
0.8922 High Similarity NPC72729
0.8818 High Similarity NPC469719
0.88 High Similarity NPC152415
0.8762 High Similarity NPC47284
0.87 High Similarity NPC55903
0.8679 High Similarity NPC53740
0.8667 High Similarity NPC475225
0.8624 High Similarity NPC322753
0.8614 High Similarity NPC245187
0.86 High Similarity NPC306074
0.86 High Similarity NPC231150
0.8598 High Similarity NPC320439
0.8585 High Similarity NPC117115
0.8571 High Similarity NPC471228
0.8571 High Similarity NPC235762
0.8545 High Similarity NPC250323
0.8534 High Similarity NPC297057
0.8529 High Similarity NPC222146
0.8505 High Similarity NPC21594
0.8462 Intermediate Similarity NPC122005
0.8462 Intermediate Similarity NPC252821
0.8455 Intermediate Similarity NPC470770
0.8455 Intermediate Similarity NPC176279
0.8455 Intermediate Similarity NPC77772
0.8455 Intermediate Similarity NPC260323
0.8455 Intermediate Similarity NPC266937
0.8447 Intermediate Similarity NPC202986
0.844 Intermediate Similarity NPC58865
0.8431 Intermediate Similarity NPC316301
0.8431 Intermediate Similarity NPC289769
0.8431 Intermediate Similarity NPC27323
0.8426 Intermediate Similarity NPC66834
0.8426 Intermediate Similarity NPC151477
0.8407 Intermediate Similarity NPC474358
0.8407 Intermediate Similarity NPC154511
0.8407 Intermediate Similarity NPC247858
0.8407 Intermediate Similarity NPC474387
0.8407 Intermediate Similarity NPC257540
0.8407 Intermediate Similarity NPC137496
0.8396 Intermediate Similarity NPC269212
0.8393 Intermediate Similarity NPC195922
0.8381 Intermediate Similarity NPC225506
0.8381 Intermediate Similarity NPC211885
0.8381 Intermediate Similarity NPC174911
0.8378 Intermediate Similarity NPC62867
0.8378 Intermediate Similarity NPC177962
0.8365 Intermediate Similarity NPC77492
0.8364 Intermediate Similarity NPC141782
0.8364 Intermediate Similarity NPC13482
0.8333 Intermediate Similarity NPC306884
0.8333 Intermediate Similarity NPC155072
0.8333 Intermediate Similarity NPC94139
0.8333 Intermediate Similarity NPC147284
0.8333 Intermediate Similarity NPC162314
0.8333 Intermediate Similarity NPC3358
0.8333 Intermediate Similarity NPC210497
0.8318 Intermediate Similarity NPC238696
0.8318 Intermediate Similarity NPC272029
0.8318 Intermediate Similarity NPC475580
0.8318 Intermediate Similarity NPC254965
0.8318 Intermediate Similarity NPC327811
0.8317 Intermediate Similarity NPC192
0.8302 Intermediate Similarity NPC477685
0.83 Intermediate Similarity NPC27974
0.8235 Intermediate Similarity NPC304541
0.8235 Intermediate Similarity NPC155908
0.8208 Intermediate Similarity NPC129373
0.8208 Intermediate Similarity NPC48730
0.8208 Intermediate Similarity NPC248396
0.82 Intermediate Similarity NPC407
0.82 Intermediate Similarity NPC307235
0.8198 Intermediate Similarity NPC132720
0.819 Intermediate Similarity NPC152097
0.819 Intermediate Similarity NPC156313
0.819 Intermediate Similarity NPC225464
0.8174 Intermediate Similarity NPC477136
0.8173 Intermediate Similarity NPC8392
0.8173 Intermediate Similarity NPC144682
0.8158 Intermediate Similarity NPC35797
0.8158 Intermediate Similarity NPC192948
0.8148 Intermediate Similarity NPC244513
0.8148 Intermediate Similarity NPC218879
0.8148 Intermediate Similarity NPC227458
0.8142 Intermediate Similarity NPC715
0.8131 Intermediate Similarity NPC80800
0.8131 Intermediate Similarity NPC12221
0.8125 Intermediate Similarity NPC151537
0.8125 Intermediate Similarity NPC224527
0.8125 Intermediate Similarity NPC469912
0.812 Intermediate Similarity NPC68339
0.812 Intermediate Similarity NPC99734
0.8113 Intermediate Similarity NPC260775
0.8113 Intermediate Similarity NPC92730
0.8108 Intermediate Similarity NPC299568
0.8108 Intermediate Similarity NPC186385
0.8103 Intermediate Similarity NPC48342
0.8103 Intermediate Similarity NPC164649
0.81 Intermediate Similarity NPC155393
0.8091 Intermediate Similarity NPC204901
0.8091 Intermediate Similarity NPC232523
0.8091 Intermediate Similarity NPC158253
0.8087 Intermediate Similarity NPC141001
0.8087 Intermediate Similarity NPC92
0.8087 Intermediate Similarity NPC471668
0.8087 Intermediate Similarity NPC219112
0.8087 Intermediate Similarity NPC469663
0.8087 Intermediate Similarity NPC308311
0.8087 Intermediate Similarity NPC38893
0.8087 Intermediate Similarity NPC477137
0.8077 Intermediate Similarity NPC76938
0.8073 Intermediate Similarity NPC37802
0.807 Intermediate Similarity NPC471534
0.807 Intermediate Similarity NPC268160
0.8056 Intermediate Similarity NPC108497
0.8053 Intermediate Similarity NPC228452
0.8053 Intermediate Similarity NPC228425
0.8053 Intermediate Similarity NPC46940
0.8053 Intermediate Similarity NPC302371
0.8051 Intermediate Similarity NPC328504
0.8049 Intermediate Similarity NPC266868
0.8039 Intermediate Similarity NPC258219
0.8039 Intermediate Similarity NPC123273
0.8039 Intermediate Similarity NPC318325
0.8039 Intermediate Similarity NPC242240
0.8037 Intermediate Similarity NPC70677
0.8037 Intermediate Similarity NPC130756
0.8037 Intermediate Similarity NPC12931
0.8034 Intermediate Similarity NPC473974
0.8034 Intermediate Similarity NPC31296
0.8034 Intermediate Similarity NPC258366
0.8034 Intermediate Similarity NPC79933
0.8019 Intermediate Similarity NPC474073
0.8019 Intermediate Similarity NPC475078
0.8018 Intermediate Similarity NPC174981
0.8018 Intermediate Similarity NPC11554
0.8017 Intermediate Similarity NPC304510
0.8017 Intermediate Similarity NPC172219
0.8 Intermediate Similarity NPC286904
0.8 Intermediate Similarity NPC147179
0.8 Intermediate Similarity NPC201662
0.8 Intermediate Similarity NPC246760
0.8 Intermediate Similarity NPC12640
0.8 Intermediate Similarity NPC150837
0.8 Intermediate Similarity NPC477814
0.8 Intermediate Similarity NPC32714
0.8 Intermediate Similarity NPC99836
0.8 Intermediate Similarity NPC84999
0.7982 Intermediate Similarity NPC120719
0.7981 Intermediate Similarity NPC271440
0.7981 Intermediate Similarity NPC29373
0.7966 Intermediate Similarity NPC318552
0.7966 Intermediate Similarity NPC190501
0.7965 Intermediate Similarity NPC54373
0.7965 Intermediate Similarity NPC95716
0.7965 Intermediate Similarity NPC275627
0.7949 Intermediate Similarity NPC154030
0.7949 Intermediate Similarity NPC471671
0.7949 Intermediate Similarity NPC206
0.7946 Intermediate Similarity NPC314187
0.7946 Intermediate Similarity NPC33728
0.7946 Intermediate Similarity NPC19808
0.7941 Intermediate Similarity NPC25493
0.7941 Intermediate Similarity NPC19680
0.7941 Intermediate Similarity NPC113460
0.7931 Intermediate Similarity NPC308828
0.7909 Intermediate Similarity NPC471350
0.7899 Intermediate Similarity NPC474175
0.7899 Intermediate Similarity NPC32322
0.7899 Intermediate Similarity NPC241001
0.7899 Intermediate Similarity NPC259703
0.7895 Intermediate Similarity NPC471179
0.7895 Intermediate Similarity NPC26615
0.789 Intermediate Similarity NPC233827
0.789 Intermediate Similarity NPC168393
0.789 Intermediate Similarity NPC24327
0.789 Intermediate Similarity NPC12870
0.7885 Intermediate Similarity NPC204210
0.7881 Intermediate Similarity NPC469644
0.7881 Intermediate Similarity NPC93071
0.7881 Intermediate Similarity NPC126002
0.7876 Intermediate Similarity NPC224870
0.7864 Intermediate Similarity NPC177420
0.7864 Intermediate Similarity NPC280347
0.7864 Intermediate Similarity NPC98772
0.7863 Intermediate Similarity NPC320864
0.7863 Intermediate Similarity NPC16030
0.785 Intermediate Similarity NPC32674
0.7843 Intermediate Similarity NPC23167
0.7843 Intermediate Similarity NPC184169
0.7838 Intermediate Similarity NPC271274
0.7838 Intermediate Similarity NPC469913

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC64586 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9 High Similarity NPD288 Approved
0.89 High Similarity NPD844 Approved
0.8558 High Similarity NPD289 Clinical (unspecified phase)
0.8431 Intermediate Similarity NPD1432 Clinical (unspecified phase)
0.8333 Intermediate Similarity NPD845 Approved
0.8173 Intermediate Similarity NPD1809 Phase 2
0.812 Intermediate Similarity NPD4059 Approved
0.8108 Intermediate Similarity NPD4750 Phase 3
0.8103 Intermediate Similarity NPD3091 Approved
0.8053 Intermediate Similarity NPD7635 Approved
0.7966 Intermediate Similarity NPD2932 Approved
0.7966 Intermediate Similarity NPD3019 Approved
0.7944 Intermediate Similarity NPD3020 Approved
0.7928 Intermediate Similarity NPD2342 Discontinued
0.7838 Intermediate Similarity NPD1445 Approved
0.7838 Intermediate Similarity NPD1444 Approved
0.7833 Intermediate Similarity NPD3092 Approved
0.7788 Intermediate Similarity NPD1792 Phase 2
0.7667 Intermediate Similarity NPD3095 Discontinued
0.7664 Intermediate Similarity NPD2859 Approved
0.7664 Intermediate Similarity NPD2860 Approved
0.7636 Intermediate Similarity NPD940 Approved
0.7636 Intermediate Similarity NPD846 Approved
0.7632 Intermediate Similarity NPD3022 Approved
0.7632 Intermediate Similarity NPD3021 Approved
0.7581 Intermediate Similarity NPD3094 Phase 2
0.757 Intermediate Similarity NPD2934 Approved
0.757 Intermediate Similarity NPD2933 Approved
0.7549 Intermediate Similarity NPD111 Approved
0.7521 Intermediate Similarity NPD1751 Approved
0.746 Intermediate Similarity NPD5736 Approved
0.7458 Intermediate Similarity NPD1793 Approved
0.7458 Intermediate Similarity NPD1791 Approved
0.7381 Intermediate Similarity NPD4624 Approved
0.736 Intermediate Similarity NPD6696 Suspended
0.7317 Intermediate Similarity NPD3026 Approved
0.7317 Intermediate Similarity NPD3023 Approved
0.7295 Intermediate Similarity NPD3024 Approved
0.7295 Intermediate Similarity NPD3025 Approved
0.725 Intermediate Similarity NPD6671 Approved
0.7244 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7236 Intermediate Similarity NPD4626 Approved
0.7231 Intermediate Similarity NPD6663 Approved
0.7213 Intermediate Similarity NPD2226 Clinical (unspecified phase)
0.7203 Intermediate Similarity NPD6124 Clinical (unspecified phase)
0.719 Intermediate Similarity NPD7325 Clinical (unspecified phase)
0.7167 Intermediate Similarity NPD497 Approved
0.7154 Intermediate Similarity NPD4093 Discontinued
0.7143 Intermediate Similarity NPD4749 Approved
0.7143 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.712 Intermediate Similarity NPD5350 Clinical (unspecified phase)
0.712 Intermediate Similarity NPD5351 Clinical (unspecified phase)
0.7109 Intermediate Similarity NPD2194 Approved
0.7109 Intermediate Similarity NPD2195 Approved
0.7105 Intermediate Similarity NPD9500 Approved
0.7097 Intermediate Similarity NPD4589 Approved
0.7083 Intermediate Similarity NPD2234 Approved
0.7083 Intermediate Similarity NPD2228 Approved
0.7083 Intermediate Similarity NPD498 Approved
0.7083 Intermediate Similarity NPD2229 Approved
0.7083 Intermediate Similarity NPD496 Approved
0.7083 Intermediate Similarity NPD7159 Clinical (unspecified phase)
0.7083 Intermediate Similarity NPD495 Approved
0.708 Intermediate Similarity NPD1242 Phase 1
0.7068 Intermediate Similarity NPD4097 Suspended
0.7054 Intermediate Similarity NPD3637 Approved
0.7054 Intermediate Similarity NPD3635 Approved
0.7054 Intermediate Similarity NPD1712 Approved
0.7054 Intermediate Similarity NPD2861 Phase 2
0.7054 Intermediate Similarity NPD3636 Approved
0.7045 Intermediate Similarity NPD3620 Phase 2
0.7045 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7023 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7008 Intermediate Similarity NPD5327 Phase 3
0.7 Intermediate Similarity NPD2605 Approved
0.7 Intermediate Similarity NPD2606 Approved
0.6984 Remote Similarity NPD1201 Approved
0.6963 Remote Similarity NPD7742 Approved
0.6963 Remote Similarity NPD7743 Approved
0.696 Remote Similarity NPD2286 Discontinued
0.696 Remote Similarity NPD1778 Approved
0.6957 Remote Similarity NPD5700 Clinical (unspecified phase)
0.6947 Remote Similarity NPD5156 Approved
0.6947 Remote Similarity NPD4625 Phase 3
0.6947 Remote Similarity NPD5155 Approved
0.6942 Remote Similarity NPD1398 Phase 1
0.694 Remote Similarity NPD6353 Approved
0.6935 Remote Similarity NPD5304 Approved
0.6935 Remote Similarity NPD5303 Approved
0.6929 Remote Similarity NPD2233 Approved
0.6929 Remote Similarity NPD2232 Approved
0.6929 Remote Similarity NPD2230 Approved
0.6917 Remote Similarity NPD228 Approved
0.6917 Remote Similarity NPD4140 Approved
0.6911 Remote Similarity NPD7340 Approved
0.6911 Remote Similarity NPD405 Clinical (unspecified phase)
0.6903 Remote Similarity NPD9273 Approved
0.6897 Remote Similarity NPD9608 Approved
0.6897 Remote Similarity NPD9610 Approved
0.6885 Remote Similarity NPD1476 Clinical (unspecified phase)
0.688 Remote Similarity NPD5691 Approved
0.688 Remote Similarity NPD4235 Clinical (unspecified phase)
0.6875 Remote Similarity NPD1755 Approved
0.687 Remote Similarity NPD3594 Approved
0.687 Remote Similarity NPD3595 Approved
0.6866 Remote Similarity NPD5735 Approved
0.6829 Remote Similarity NPD709 Approved
0.6815 Remote Similarity NPD2157 Approved
0.68 Remote Similarity NPD9087 Approved
0.68 Remote Similarity NPD7330 Discontinued
0.6788 Remote Similarity NPD6099 Approved
0.6788 Remote Similarity NPD6100 Approved
0.6772 Remote Similarity NPD1981 Approved
0.6772 Remote Similarity NPD1983 Approved
0.6772 Remote Similarity NPD3143 Discontinued
0.6772 Remote Similarity NPD1980 Approved
0.6769 Remote Similarity NPD4339 Clinical (unspecified phase)
0.6769 Remote Similarity NPD1470 Approved
0.6763 Remote Similarity NPD3638 Discontinued
0.6748 Remote Similarity NPD9614 Approved
0.6748 Remote Similarity NPD9618 Approved
0.6746 Remote Similarity NPD4196 Clinical (unspecified phase)
0.6739 Remote Similarity NPD5762 Approved
0.6739 Remote Similarity NPD5763 Approved
0.6721 Remote Similarity NPD9379 Approved
0.6721 Remote Similarity NPD9377 Approved
0.6694 Remote Similarity NPD7157 Approved
0.6692 Remote Similarity NPD1283 Approved
0.6667 Remote Similarity NPD4060 Phase 1
0.6667 Remote Similarity NPD5283 Phase 1
0.6667 Remote Similarity NPD7741 Discontinued
0.6667 Remote Similarity NPD4717 Approved
0.6667 Remote Similarity NPD4720 Approved
0.6667 Remote Similarity NPD4718 Approved
0.6667 Remote Similarity NPD3070 Discontinued
0.6667 Remote Similarity NPD7910 Clinical (unspecified phase)
0.6641 Remote Similarity NPD3496 Discontinued
0.6641 Remote Similarity NPD2688 Clinical (unspecified phase)
0.664 Remote Similarity NPD7636 Approved
0.664 Remote Similarity NPD4230 Clinical (unspecified phase)
0.6638 Remote Similarity NPD3028 Approved
0.6638 Remote Similarity NPD1616 Discontinued
0.6637 Remote Similarity NPD1693 Approved
0.6614 Remote Similarity NPD1651 Approved
0.6614 Remote Similarity NPD5585 Approved
0.6614 Remote Similarity NPD1357 Approved
0.6613 Remote Similarity NPD475 Phase 2
0.6607 Remote Similarity NPD1088 Approved
0.6602 Remote Similarity NPD9294 Approved
0.6593 Remote Similarity NPD8032 Phase 2
0.6589 Remote Similarity NPD1610 Phase 2
0.6589 Remote Similarity NPD1611 Approved
0.6587 Remote Similarity NPD9615 Approved
0.6587 Remote Similarity NPD9613 Approved
0.6587 Remote Similarity NPD9616 Approved
0.6585 Remote Similarity NPD1138 Approved
0.6583 Remote Similarity NPD290 Approved
0.6549 Remote Similarity NPD8131 Suspended
0.6545 Remote Similarity NPD1101 Approved
0.6544 Remote Similarity NPD6346 Approved
0.6538 Remote Similarity NPD9088 Approved
0.6535 Remote Similarity NPD316 Approved
0.6529 Remote Similarity NPD2684 Approved
0.6525 Remote Similarity NPD3683 Approved
0.6525 Remote Similarity NPD2211 Approved
0.6525 Remote Similarity NPD3681 Approved
0.6525 Remote Similarity NPD2209 Approved
0.6522 Remote Similarity NPD7718 Clinical (unspecified phase)
0.6504 Remote Similarity NPD1139 Approved
0.6504 Remote Similarity NPD1137 Approved
0.65 Remote Similarity NPD968 Approved
0.65 Remote Similarity NPD4725 Approved
0.65 Remote Similarity NPD4721 Approved
0.65 Remote Similarity NPD4726 Approved
0.6493 Remote Similarity NPD4908 Phase 1
0.6479 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6475 Remote Similarity NPD3299 Clinical (unspecified phase)
0.6475 Remote Similarity NPD9380 Clinical (unspecified phase)
0.6462 Remote Similarity NPD1281 Approved
0.6454 Remote Similarity NPD4256 Phase 2
0.6454 Remote Similarity NPD4257 Approved
0.6441 Remote Similarity NPD4818 Approved
0.6441 Remote Similarity NPD4817 Approved
0.6434 Remote Similarity NPD2668 Approved
0.6434 Remote Similarity NPD2667 Approved
0.6434 Remote Similarity NPD5238 Clinical (unspecified phase)
0.6429 Remote Similarity NPD1086 Approved
0.6429 Remote Similarity NPD1089 Approved
0.6429 Remote Similarity NPD256 Approved
0.6429 Remote Similarity NPD1090 Approved
0.6429 Remote Similarity NPD255 Approved
0.6423 Remote Similarity NPD2238 Phase 2
0.6423 Remote Similarity NPD9280 Clinical (unspecified phase)
0.6418 Remote Similarity NPD4212 Discontinued
0.6414 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6414 Remote Similarity NPD3645 Discontinued
0.6412 Remote Similarity NPD1608 Approved
0.6406 Remote Similarity NPD1759 Phase 1
0.64 Remote Similarity NPD4869 Clinical (unspecified phase)
0.6397 Remote Similarity NPD4907 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data